EBV
Clinical trials for EBV explained in plain language.
Never miss a new study
Get alerted when new EBV trials appear
Sign up with your email to follow new studies for EBV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a nanoparticle vaccine stop the virus behind mono and some cancers?
⭐️ VACCINE ⭐️ CompletedThis early-stage trial is testing whether a new vaccine can safely train the immune system to fight Epstein-Barr virus (EBV), which causes infectious mononucleosis and is linked to several cancers. Healthy adults aged 18 to 29, both with and without prior EBV infection, will rece…
Matched conditions: EBV
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Aug 15, 2026 00:00 UTC
-
Which EBV test is most accurate? study puts three automated assays Head-to-Head
Diagnosis CompletedThis study compares three automated blood tests (Abbott Architect, Siemens Immulite, and Diasorin Liaison) for diagnosing Epstein-Barr virus (EBV) infection. Researchers analyzed 91 blood samples from patients aged 3 to 82 to see how well each test detects key markers of EBV infe…
Matched conditions: EBV
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC